Overcoming Resistance to Targeted Anticancer Therapies through Small-Molecule-Mediated MEK Degradation.
Overcoming Resistance to Targeted Anticancer Therapies through Small-Molecule-Mediated MEK Degradation.
复制标题
DOI：
10.1016/j.chembiol.2018.05.008
复制
发表时间：
2018-08-16
影响因子：
8.6
通讯作者：
Hergenrother PJ
中科院分区：
文献类型：
--
作者：
Peh J;Boudreau MW;Smith HM;Hergenrother PJ
The discovery of mutant or fusion kinases that drive oncogenesis, and the subsequent approval of specific inhibitors for these enzymes, has been instrumental in the management of some cancers. However, acquired resistance remains a significant problem in the clinic, limiting the long-term effectiveness of most of these drugs. Here we demonstrate a general strategy to overcome this resistance through drug-induced MEK cleavage (via direct procaspase-3 activation) combined with targeted kinase inhibition. This combination effect is shown to be general across diverse tumor histologies (melanoma, lung cancer, and leukemia) and driver mutations (mutant BRAF or EGFR, fusion kinases EML4-ALK and BCR-ABL). Caspase-3-mediated degradation of MEK kinases results in sustained pathway inhibition and substantially delayed or eliminated resistance in cancer cells in a manner far superior to combinations with MEK inhibitors. These data suggest the generality of drug-mediated MEK kinase cleavage as a therapeutic strategy to prevent resistance to targeted anticancer therapies. Rapid onset of resistance to targeted kinase inhibitors limits their use in treating advanced cancers. Peh et al. show that combination of diverse kinase inhibitors with a procaspase-3 activating compound (PAC-1), leads to degradation of MEK1/2, dramatically delaying acquired resistance.
登录
查看更多内容
影响因子：
11.2
作者：
Eberlein CA;Stetson D;Markovets AA;Al-Kadhimi KJ;Lai Z;Fisher PR;Meador CB;Spitzler P;Ichihara E;Ross SJ;Ahdesmaki MJ;Ahmed A;Ratcliffe LE;O'Brien EL;Barnes CH;Brown H;Smith PD;Dry JR;Beran G;Thress KS;Dougherty B;Pao W;Cross DA
通讯作者：
Cross DA
影响因子：
2.1
作者：
Kitagawa, Daisuke;Yokota, Koichi;Kirii, Yasuyuki
通讯作者：
Kirii, Yasuyuki
影响因子：
8
作者：
Gazdar, A. F.
通讯作者：
Gazdar, A. F.
影响因子：
28.2
作者：
Lin JJ;Riely GJ;Shaw AT
通讯作者：
Shaw AT
影响因子：
1.9
作者：
Huang, Jian-qing;Liang, Hong-ling;Jin, Tian-en
通讯作者：
Jin, Tian-en